Stephanie Greene Named Chief of Pediatric Neurosurgery at Duke
Stephanie Greene, MD, a nationally recognized expert in pediatric vascular neurosurgery and congenital neurosurgical disorders, has been named chief of pediatric neurosurgery and professor of neurosurgery and pediatrics in the Duke Department of Neurosurgery, effective April 30, 2024.
Goodwin Named Spine Services Director for Duke Center for Brain and Spine Metastasis
C. Rory Goodwin, MD, PhD, has been named spine services director of the Duke Center for Brain and Spine Metastasis. In this new role, Goodwin will lead all DCBSM spine services.
Simon Gregory Awarded Distinguished Professorship
Simon Gregory, PhD, has been named the Margaret Harris and David Silverman Distinguished Professor of Neurosurgery at Duke University.
Remembering Takanori Fukushima
We in Duke Neurosurgery are saddened by the news of the death of Takanori Fukushima, MD, a consulting professor of neurosurgery at Duke University since 1999, and a giant in the field of neurosurgery.
Duke team reaches milestone for LITT procedures
Today, Peter Fecci, MD, PhD, and team were celebrated for hitting the 200-case milestone for laser interstitial thermal therapy (LITT) cases.
Duke researchers publish protocol for processing human spinal cord tumors
Duke researchers have published a novel protocol for collecting and processing human spinal cord tumors during spine surgery for single-cell studies.
Study identifies Duke researchers as top cited in past 20 years for immunotherapy for glioma
A new study of advancements in immunotherapy for glioma analyzed the 100 most cited papers of the past 20 years and concluded that Duke researchers had made the biggest impact in the field.
Duke Center for Brain and Spine Metastasis Recognizes World Cancer Day
World Cancer Day is a day for education and awareness surrounding cancer and its prevention, detection, and treatment.
Duke conducting first-in-human studies of cell transplantation for epilepsy
A groundbreaking clinical trial is taking a new approach to treat seizures: brain cell transplantation.
Drug born at Duke improves survival in people with advanced brain cancer
Ines Batinic-Haberle, PhD, professor emeritus of radiation oncology at Duke University School of Medicine, created hundreds of compounds before she hit upon the right one.